Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04967599 · ClinicalTrials.gov registry record · NA
Alcohol Metabolism and Disease Risk in Asians
A NA study, sponsored by University of Southern California.
- Completed
- Registry status
- NA
- Development phase
- 360
- Enrollment target
NCT04967599 is a NA study that has completed, run by University of Southern California. The registered enrollment target is 360 participants.
The verdict
NCT04967599, a NA study, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- NA
- Development phase
- 360 participants
- Enrollment target
Study Summary
The primary pathway of alcohol metabolism involves two main enzymes, alcohol and aldehyde dehydrogenase. Several genes that encode these enzymes have variants that alter the rate of alcohol metabolism and increase levels of acetaldehyde. The variant ALDH2\*2 allele is associated with the flushing response (i.e., Asian glow) and is found almost exclusively in individuals of east Asian descent. Although having variant ALDH2 alleles is protective against heavy drinking and alcohol use disorders, for those who do drink, these variants also are associated with elevations in risk for several health problems. The premise of this study is that we can affect early drinking behavior through personalized communication about these health-related risks.
Interventions
- BEHAVIORAL Phenotype Feedback Intervention
- BEHAVIORAL Genotype Feedback Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 360 participants |
| Start Date | 2021-08-18 |
| Est. Completion | 2023-01-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04967599
The ClinicalTrials.gov registry entry for NCT04967599 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 360 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Phenotype Feedback Intervention is the first listed.
NCT04967599 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04967599 about?
NCT04967599 is a clinical study titled "Alcohol Metabolism and Disease Risk in Asians". The primary pathway of alcohol metabolism involves two main enzymes, alcohol and aldehyde dehydrogenase. Several genes that encode these enzymes have variants that alter the rate of alcohol metabolism and increase levels of acetaldehyde. The variant ALDH2\*2 allele is associated with the flushing re...
What is the current status of trial NCT04967599?
This trial is currently completed. It is a NA study. The enrollment target is 360 participants. The study started on 2021-08-18. Estimated completion is 2023-01-18.
What interventions are being tested in trial NCT04967599?
The interventions under investigation include: Phenotype Feedback Intervention (BEHAVIORAL), Genotype Feedback Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04967599?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.